MedPath

Laboratorios Silanes, S.A. de C.V.

🇲🇽Mexico
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trial to Evaluate Safety and pK Profile of Metformin Glycinate in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
First Posted Date
2012-03-22
Last Posted Date
2018-01-30
Lead Sponsor
Laboratorios Silanes S.A. de C.V.
Target Recruit Count
49
Registration Number
NCT01560481
Locations
🇪🇸

Centre d'Investigació de Medicaments Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

BIOAVAILABILITY OF Glimepiride/Extended Release Metformin (GLI/METXR): High Fat Diet Study

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Glimepiride/ Extended release Metformin
First Posted Date
2011-09-21
Last Posted Date
2021-05-06
Lead Sponsor
Laboratorios Silanes S.A. de C.V.
Target Recruit Count
24
Registration Number
NCT01437813
Locations
🇲🇽

Investigación Farmacológica Y Biofarmaceutica, S.A. de C.V., México, Mexico

BIOAVAILABILITY OF GLI/METXR (4/850 mg)

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2011-09-21
Last Posted Date
2021-05-06
Lead Sponsor
Laboratorios Silanes S.A. de C.V.
Target Recruit Count
24
Registration Number
NCT01437800
Locations
🇲🇽

Investigacion Farmacologica Y Biofarmaceutica, S.A. de C.V., México, Mexico

Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes Patients

Phase 4
Completed
Conditions
Endothelial Dysfunction
Diabetes Mellitus
Interventions
Drug: Glimepiride/metformin
First Posted Date
2011-09-07
Last Posted Date
2011-09-07
Lead Sponsor
Laboratorios Silanes S.A. de C.V.
Target Recruit Count
16
Registration Number
NCT01429818
Locations
🇲🇽

Unidad PET Ciclotrón. Facultad de Medicina. Universidad Nacional Autónoma de México, Mexico city, Distrito Federal, Mexico

Metformin Glycinate on Metabolic Control and Inflammatory Mediators in Type 2 Diabetes

Phase 3
Completed
Conditions
Type 2 Diabetes
Interventions
First Posted Date
2011-07-01
Last Posted Date
2018-01-30
Lead Sponsor
Laboratorios Silanes S.A. de C.V.
Target Recruit Count
203
Registration Number
NCT01386671
Locations
🇲🇽

Unidad Antidiabética Integral, Mexico City, AA, Mexico

🇲🇽

Unidad de Investigacion en Epidemiologia Clinica. UMAE Hospital de Especialidades Centro Medico Nacional Siglo XXI. Instituto Mexicano del Seguro Social, Mexico City, Distrito Federal, Mexico

🇲🇽

Instituto de terapéutica experimental y clínica (INTEC), Guadalajara, Jalisco, Mexico

and more 1 locations

Gastric Tolerability and Pharmacokinetics of DMMET-01

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2009-08-18
Last Posted Date
2018-01-30
Lead Sponsor
Laboratorios Silanes S.A. de C.V.
Target Recruit Count
12
Registration Number
NCT00960882
Locations
🇲🇽

Pharmacology and toxicology department, UANL, Monterrey, Nuevo León, Mexico

Tolerability and Pharmacokinetics of Metformin and Metformin Extended Release (ER)

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2009-07-17
Last Posted Date
2018-01-30
Lead Sponsor
Laboratorios Silanes S.A. de C.V.
Target Recruit Count
24
Registration Number
NCT00941239
Locations
🇲🇽

Pharmacology and toxicology department, UANL, Monterrey, Nuevo León, Mexico

Effect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes Mellitus

Phase 4
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Drug: metformin/glimepiride combination
First Posted Date
2009-07-17
Last Posted Date
2010-05-18
Lead Sponsor
Laboratorios Silanes S.A. de C.V.
Target Recruit Count
28
Registration Number
NCT00941161
Locations
🇲🇽

Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, Guadalajara, Jalisco, Mexico

Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese Patients

Phase 3
Conditions
Obesity
Interventions
Drug: Sibutramine-Metformin
First Posted Date
2009-07-17
Last Posted Date
2009-07-17
Lead Sponsor
Laboratorios Silanes S.A. de C.V.
Target Recruit Count
60
Registration Number
NCT00941382
Locations
🇲🇽

Centro Universitario de Ciencias de la Salud, Guadalajara, Jalisco, Mexico

Study on DMMET-01 Versus Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetes Patients

Phase 2
Completed
Conditions
Diabetes Type 2
Interventions
First Posted Date
2009-07-16
Last Posted Date
2010-05-18
Lead Sponsor
Laboratorios Silanes S.A. de C.V.
Target Recruit Count
20
Registration Number
NCT00940472
Locations
🇲🇽

Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jal, Mexico

© Copyright 2025. All Rights Reserved by MedPath